Related references
Note: Only part of the references are listed.Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2021)
Cellular Senescence as a Therapeutic Target for Age-Related Diseases: A Review
Mateo Amaya-Montoya et al.
ADVANCES IN THERAPY (2020)
Alzheimer disease and aducanumab: adjusting our approach
Dennis J. Selkoe
NATURE REVIEWS NEUROLOGY (2019)
Stem cell therapy in Alzheimer's disease: possible benefits and limiting drawbacks
Masoume Alipour et al.
MOLECULAR BIOLOGY REPORTS (2019)
Physiological and pathological effects of amyloid-β species in neural stem cell biology
Adela Bernabeu-Zornoza et al.
NEURAL REGENERATION RESEARCH (2019)
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
Konstantina G. Yiannopoulou et al.
BIOMEDICINES (2019)
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer's disease
Alison K. Ower et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2018)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
Bone morphogenetic protein signaling: a promising target for white matter protection in perinatal brain injury
Jill Chang et al.
NEURAL REGENERATION RESEARCH (2018)
Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging
Dena S. Leeman et al.
SCIENCE (2018)
Modeling Late-Onset Sporadic Alzheimer''s Disease through BMI1 Deficiency
Anthony Flamier et al.
CELL REPORTS (2018)
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Tyler J. Bussian et al.
NATURE (2018)
Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris
Nicholas Schaum et al.
NATURE (2018)
Non-monotonic Changes in Progenitor Cell Behavior and Gene Expression during Aging of the Adult V-SVZ Neural Stem Cell Niche
Maria Apostolopoulou et al.
STEM CELL REPORTS (2017)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Increased bone morphogenetic protein signaling contributes to age-related declines in neurogenesis and cognition
Emily A. Meyers et al.
NEUROBIOLOGY OF AGING (2016)
Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease
Lana M. Osborn et al.
PROGRESS IN NEUROBIOLOGY (2016)
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu et al.
AGING CELL (2015)
Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease
Elizabeta Gjoneska et al.
NATURE (2015)
Age-Associated Increase in BMP Signaling Inhibits Hippocampal Neurogenesis
Hanadie Yousef et al.
STEM CELLS (2015)
Secreted type of amyloid precursor protein induces glial differentiation by stimulating the BMP/Smad signaling pathway
Young-Don Kwak et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
Continuous Postnatal Neurogenesis Contributes to Formation of the Olfactory Bulb Neural Circuits and Flexible Olfactory Associative Learning
Masayuki Sakamoto et al.
JOURNAL OF NEUROSCIENCE (2014)
A cell-intrinsic role for TLR2 MYD88 in intestinal and breast epithelia and oncogenesis
Ferenc A. Scheeren et al.
NATURE CELL BIOLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
In Vivo RNAi Screen for BMI1 Targets Identifies TGF-β/BMP-ER Stress Pathways as Key Regulators of Neural- and Malignant Glioma-Stem Cell Homeostasis
Gaetano Gargiulo et al.
CANCER CELL (2013)
Usp16 contributes to somatic stem-cell defects in Down's syndrome
Maddalena Adorno et al.
NATURE (2013)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Liesi E. Hebert et al.
NEUROLOGY (2013)
A Shortened Barnes Maze Protocol Reveals Memory Deficits at 4-Months of Age in the Triple-Transgenic Mouse Model of Alzheimer's Disease
Aida Attar et al.
PLOS ONE (2013)
Amyloid-β oligomers regulate the properties of human neural stem cells through GSK-3β signaling
Il-Shin Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bmi1 Is Down-Regulated in the Aging Brain and Displays Antioxidant and Protective Activities in Neurons
Mohamed Abdouh et al.
PLOS ONE (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Longitudinal Assessment of A beta and Cognition in Aging and Alzheimer Disease
Victor L. Villemagne et al.
ANNALS OF NEUROLOGY (2011)
Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
Erika Pastrana et al.
CELL STEM CELL (2011)
Neurodegenerative disease and adult neurogenesis
Beate Winner et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Neurogenesis in Alzheimer's disease
Jose J. Rodriguez et al.
JOURNAL OF ANATOMY (2011)
Adult hippocampal neurogenesis and its role in Alzheimer's disease
Yangling Mu et al.
MOLECULAR NEURODEGENERATION (2011)
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Darren J. Baker et al.
NATURE (2011)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Alzheimer Disease
Rudy J. Castellani et al.
DM DISEASE-A-MONTH (2010)
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?
Bruno P. Imbimbo et al.
FRONTIERS IN AGING NEUROSCIENCE (2010)
Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain
Christopher A. Fasano et al.
GENES & DEVELOPMENT (2009)
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial
Robert C. Green et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
EdU, a new thymidine analogue for labelling proliferating cells in the nervous system
Fatemah Chehrehasa et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model
Jose J. Rodriguez et al.
NEUROREPORT (2009)
Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2
Donna M. Wilcock et al.
JOURNAL OF NEUROSCIENCE (2008)
Tarenflurbil: a shot on goal
Paul S. Aisen
LANCET NEUROLOGY (2008)
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
LANCET NEUROLOGY (2008)
BMP type I receptor inhibition reduces heterotopic ossification
Paul B. Yu et al.
NATURE MEDICINE (2008)
A critical function for β-amyloid precursor protein in neuronal migration revealed by In Utero RNA interference
Tracy L. Young-Pearse et al.
JOURNAL OF NEUROSCIENCE (2007)
Regulation of cell cycle progression and gene expression by H2A deubiquitination
Heui-Yun Joo et al.
NATURE (2007)
p16INK4a induces an age-dependent decline in islet regenerative potential
Janakiraman Krishnamurthy et al.
NATURE (2006)
Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Anna V. Molofsky et al.
NATURE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Bmi1 loss produces an increase in astroglial cells and a decrease in neural stem cell population and proliferation
D Zencak et al.
JOURNAL OF NEUROSCIENCE (2005)
Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and P19Arf senescence pathways
AV Molofsky et al.
GENES & DEVELOPMENT (2005)
Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice
SWM Bruggeman et al.
GENES & DEVELOPMENT (2005)
Neurogenic effect of β-amyloid peptide in the development of neural stem cells
MA López-Toledano et al.
JOURNAL OF NEUROSCIENCE (2004)
Early-onset and robust cerebral microvascular accumulation of amyloid β-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid β-protein precursor
J Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG
LQ Sun et al.
GENES & DEVELOPMENT (2004)
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
AV Molofsky et al.
NATURE (2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells
IK Park et al.
NATURE (2003)
Vascular pathology in Alzheimer disease: Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline
DR Thal et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Share Paper
